Press releases

(April 12, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that enrollment has begun in its clinical trial known as SYNTAX, which will compare the performance of drug-eluting...

(April 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received the Cadence Management Corporation 2004 Award for Customer Excellence in Project Management. This...

(April 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2005 on Tuesday, April 19, at 11:00...

(April 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in SunTrust Robinson Humphrey's 34th Annual Institutional Conference which is being held April 11-12 at the...

(April 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received CE Mark for three large vessel sizes (4.0mm, 4.5mm and 5.0mm) of its TAXUS® Express2™...

(April 5, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved enhancements to the Directions for Use (DFU) of the...

(March 29, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the nationwide release of a revolutionary technology to treat chronic, debilitating pain, a condition affecting...

(March 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that a jury in Delaware issued a verdict in a retrial of patent litigation between Boston Scientific and Johnson &...

(March 15, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Quincy Distribution Center as a...

(March 11, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Maple Grove, Minnesota manufacturing facility has received the 2005 Shingo Prize for Excellence in...